PAF-acether (1-O-hexadecyl/octadecyl-2-acetyl-sn-glycero-3-phosphocholine)-induced fibrinogen binding to platelets depends on metabolic energy
- PMID: 3800968
- PMCID: PMC1147218
- DOI: 10.1042/bj2380885
PAF-acether (1-O-hexadecyl/octadecyl-2-acetyl-sn-glycero-3-phosphocholine)-induced fibrinogen binding to platelets depends on metabolic energy
Abstract
A combination of CN- and 2-deoxy-D-glucose decreases the binding of fibrinogen to platelets stimulated with PAF-acether (1-O-hexadecyl/octadecyl-2-acetyl-sn-glycero-3-phosphocholine). Decreased binding is found after pretreatment with metabolic inhibitors, thereby lowering the energy content before stimulation as well as at various stages after stimulation of undisturbed cells. Binding and ATP hydrolysis occur in parallel, suggesting tight coupling between both phenomena. Energy appears to be predominantly required for exposure and maintenance of accessible binding sites, whereas the interaction between fibrinogen and the exposed sites does not depend on metabolic energy.
Similar articles
-
Kinetics of platelet-activating factor 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine-induced fibrinogen binding to human platelets.J Biol Chem. 1986 Aug 25;261(24):11071-6. J Biol Chem. 1986. PMID: 3015954
-
Binding kinetics of PAF-acether (1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) to intact human platelets.Biochem J. 1984 Nov 1;223(3):901-9. doi: 10.1042/bj2230901. Biochem J. 1984. PMID: 6150705 Free PMC article.
-
The enantiomer and the positional isomer of platelet-activating factor.Biochim Biophys Acta. 1983 Feb 22;755(3):526-30. doi: 10.1016/0304-4165(83)90260-x. Biochim Biophys Acta. 1983. PMID: 6824744
-
Platelet-activating factor (PAF-acether) induces high- and low-affinity binding of fibrinogen to human platelets via independent mechanisms.Biochem J. 1986 Dec 1;240(2):403-12. doi: 10.1042/bj2400403. Biochem J. 1986. PMID: 3101672 Free PMC article.
-
1-O-hexadecyl-2-acetyl-sn-glycero-3-phospho (N,N,N trimethyl) hexanolamine: an analogue of platelet-activating factor with partial agonist activity.Br J Pharmacol. 1991 Sep;104(1):171-7. doi: 10.1111/j.1476-5381.1991.tb12403.x. Br J Pharmacol. 1991. PMID: 1664761 Free PMC article.
Cited by
-
Protein kinase C and cyclic AMP regulate reversible exposure of binding sites for fibrinogen on the glycoprotein IIB-IIIA complex of human platelets.Biochem J. 1991 Jan 1;273(Pt 1)(Pt 1):115-20. doi: 10.1042/bj2730115. Biochem J. 1991. PMID: 1846526 Free PMC article.
-
Exposure of ligand-binding sites on platelet integrin alpha IIB/beta 3 by phosphorylation of the beta 3 subunit.Biochem J. 1996 Mar 15;314 ( Pt 3)(Pt 3):769-79. Biochem J. 1996. PMID: 8615768 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources